Delivery Order SPE2DB22D1106-SPE2DB25FFBV2
Award Date 8/6/25
Potential Completion Date 8/27/25
Potential Value $75K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $26,605.30 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Herceptin Hylecta 600mg injectable medication (10,000 5ml units). This firm fixed-price delivery order, which has no set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 16, 2025. The award represents a competitive procurement through the company's existing...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Herceptin 150 mg vials, valued at $10,681.68, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Herceptin is a critical biopharmaceutical used in cancer treatment, particularly for...
- The Defense Logistics Agency awarded a $21,363.36 delivery order to AmerisourceBergen Drug Corp for 150 mg Herceptin vials, with a completion date of September 30, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. Herceptin (trastuzumab) is a monoclonal antibody used in cancer treatment, particularly for HER2-positive breast cancer cases, making this a critical pharmaceutical supply...
- The U.S. government has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,942,502 units of Herceptin 150 mg vials. The contract has a ceiling value of $8,835.30 and a period of performance through April 2, 2024. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, which supports the Department of Defense's military treatment programs and facilities. Amerisourcebergen Drug...
- The Defense Department's Medical Supply Chain, a division of the Defense Logistics Agency, awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Herceptin 150 mg vials. This firm fixed-price delivery order, valued at $26,704.20, is scheduled for completion by September 30, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The award was competitively procured with no set-aside designation, reflecting AmerisourceBergen's...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Herceptin 150 mg vials. The $2,650.59 firm fixed-price contract has an ultimate completion date of August 8, 2024. AmerisourceBergen, through its Corporate Office division, will provide these critical oncology medications to support military treatment facilities and other government healthcare programs. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,340.84 to AmerisourceBergen Drug Corp for the supply of Herceptin 150 mg vials, a brand-name pharmaceutical product used in cancer treatment. This is a firm fixed-price delivery order with no set-aside designation, issued on September 15, 2025, with an ultimate completion date of October 6, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the place of performance location and operates as a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $10,669.36, is for the supply of HERCEPTIN HYLECTA 1S, a pharmaceutical product. The delivery order was issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of...
- The Defense Logistics Agency awarded a $7,121.12 firm fixed price delivery order to AmerisourceBergen Drug Corp for 150 mg vials of Herceptin (trastuzumab), a monoclonal antibody used in cancer treatment. The award, issued on September 18, 2025, with completion targeted for October 9, 2025, was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location and serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading global pharmaceutical distribution company, for the provision of Herceptin Hylecta 600mg-10,000 5ml. The $5,334.70 firm fixed price delivery order falls under an existing indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. This...